VanEck Biotech Financials
| BBH Etf | USD 155.12 2.47 1.57% |
Net Expense Ratio 0.0035 | 3 y Sharp Ratio (0.13) |
VanEck |
The data published in VanEck Biotech's official financial statements usually reflect VanEck Biotech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of VanEck Biotech ETF. For example, before you start analyzing numbers published by VanEck accountants, it's critical to develop an understanding of what VanEck Biotech's liquidity, profitability, and earnings quality are in the context of the VanEck space in which it operates.
Please note, the presentation of VanEck Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, VanEck Biotech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in VanEck Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of VanEck Biotech ETF. Please utilize our Beneish M Score to check the likelihood of VanEck Biotech's management manipulating its earnings.
VanEck Biotech Etf Summary
VanEck Biotech competes with Consumer Staples, Industrial Select, Consumer Discretionary, Utilities Select, and Technology Select. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NASDAQ Exchange |
| ISIN | US92189F7261 |
| CUSIP | 92189F726 57060U183 09067D201 |
| Region | Global |
| Investment Issuer | Van Eck |
| Etf Family | VanEck |
| Fund Category | Sector |
| Portfolio Concentration | Health Care |
| Benchmark | NYSE Composite |
| Phone | NA |
| Currency | USD - US Dollar |
You should never invest in VanEck Biotech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of VanEck Etf, because this is throwing your money away. Analyzing the key information contained in VanEck Biotech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
VanEck Biotech Key Financial Ratios
Generally speaking, VanEck Biotech's financial ratios allow both analysts and investors to convert raw data from VanEck Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of VanEck Biotech over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that VanEck Biotech ETF reports annually and quarterly.VanEck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Biotech's current stock value. Our valuation model uses many indicators to compare VanEck Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Biotech competition to find correlations between indicators driving VanEck Biotech's intrinsic value. More Info.VanEck Biotech ETF is the top ETF in price to earning as compared to similar ETFs. It is the top ETF in price to book as compared to similar ETFs fabricating about 0.16 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Biotech ETF is roughly 6.45 . Comparative valuation analysis is a catch-all model that can be used if you cannot value VanEck Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VanEck Biotech's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VanEck Biotech's earnings, one of the primary drivers of an investment's value.VanEck Biotech ETF Systematic Risk
VanEck Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. VanEck Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on VanEck Biotech ETF correlated with the market. If Beta is less than 0 VanEck Biotech generally moves in the opposite direction as compared to the market. If VanEck Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VanEck Biotech ETF is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VanEck Biotech is generally in the same direction as the market. If Beta > 1 VanEck Biotech moves generally in the same direction as, but more than the movement of the benchmark.
About VanEck Biotech Financials
What exactly are VanEck Biotech Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include VanEck Biotech's income statement, its balance sheet, and the statement of cash flows. Potential VanEck Biotech investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although VanEck Biotech investors may use each financial statement separately, they are all related. The changes in VanEck Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VanEck Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze VanEck Biotech Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as VanEck Biotech is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of VanEck has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if VanEck Biotech's financials are consistent with your investment objective using the following steps:- Review VanEck Biotech's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand VanEck Biotech's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare VanEck Biotech's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if VanEck Biotech's stock is overvalued or undervalued.
VanEck Biotech Thematic Clasifications
VanEck Biotech ETF is part of several thematic ideas from Sector ETFs to Health Care ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasVanEck Biotech April 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of VanEck Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of VanEck Biotech ETF. We use our internally-developed statistical techniques to arrive at the intrinsic value of VanEck Biotech ETF based on widely used predictive technical indicators. In general, we focus on analyzing VanEck Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build VanEck Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 4.04 | |||
| Value At Risk | (1.84) | |||
| Potential Upside | 1.24 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.